13128
Blog

How Is Aidoc’s Neurovascular Solution Different from Other Clinical AI Options?

Diagnosing and treating stroke, brain aneurysms and traumatic brain injuries are often a race against the clock. After all, time is brain. The good news is that advancements in AI are allowing clinicians to uncover findings faster, reducing time-to-treatment and making a life-altering difference for the patients that they care for.

But not all neuro AI is created equal. Here’s how Aidoc’s Full Brain Solution stands out among the rest.

What makes Aidoc’s neuro AI different?

It’s powered by Aidoc’s award-winning, proprietary aiOS™ platform. The platform allows us to deliver AI solutions at scale, overcoming challenges from outdated IT infrastructures and fragmented workflows. Plus, the aiOS™ integrates seamlessly within existing workflows — including all major PACS and worklist systems — to help streamline operations, maximize opportunities for appropriate interventions, coordinate care and improve patient outcomes.

Always On Identification

If AI is only looking for one pathology on a CTA scan, it might overlook others. Many clinical AI vendors use protocol based AI, meaning that specific neuro algorithms run only on specific protocols. If a concern isn’t suspected, it’s not going to get flagged — leading to overlooked findings and potentially negative patient outcomes.

Aidoc’s Full Brain Solution runs all relevant AI algorithms on a facility’s CTA scans to flag both the expected and the unexpected. Beyond the primary purpose for the scan, Aidoc can surface patients with incidental findings such as brain aneurysm or stroke.

Surfacing unexpected findings along with suspected pathologies enables: 

  • Increased disease awareness
  • More opportunities to intervene before symptoms worsen
  • Faster time-to-treatment
  • Improved patient outcomes

Extensive Vessel Anatomy Check

Aidoc is the only healthcare AI company with FDA clearance to flag both large and medium vessel occlusions in the anterior and posterior circulation. That means more patients have a better chance of being routed for appropriate treatment faster.

“With Aidoc’s Full Brain Solution, we can now broaden these advancements to benefit a significantly larger patient population, leading to improved care and ultimately better patient outcomes.”

Brian Mason, MD
Senior NeuroEndovascular Surgeon and Associate Professor, Carle Foundation

Aidoc’s clinical algorithms look for all vessel occlusions (anterior and posterior, including LVO and MeVO), CT perfusion, brain aneurysms, intracranial hemorrhage, midline shift measurement, C-spine fractures and vertebral compression fractures.

This full brain coverage helps: 

  • Reduce your risk of missing critical findings
  • Prevent costly malpractice penalties
  • Increase your opportunity for appropriate interventions

Enhanced Clinical Data Integration

Data integration capabilities help neuro care teams, too. As soon as an algorithm flags a suspected finding, the aiOS™ automatically alerts relevant care teams via a mobile app so they can begin treatment plans. The app integrates real-time EHR data, images, radiology reports and a HIPAA-compliant chat function to help clinicians:

  • View critical patient information in one streamlined place
  • Assess patients while they’re on the move
  • Discuss treatment options with multidisciplinary teams faster
  • Reduce time-to-treatment

Schedule a demo to learn more about Aidoc’s clinically validated, end-to-end neurovascular solutions.

Explore the Latest AI Insights, Trends and Research

Laci Costa
Laci Costa is the Director of Neurovascular Product Marketing at Aidoc. She leads marketing and commercial strategy for the neuro AI portfolio of products. She has 16 years of experience working in the medical device and healthcare industry, with over 12 years dedicated to neurovascular solutions. Costa's known for her expertise in the neurovascular industry, go-to-market experience with new technologies and upstream and downstream product marketing leadership. She's held various leadership positions in product marketing, clinical education and professional affairs spanning across start-up organizations to large publicly traded companies. Costa holds a bachelor’s degree in psychology from the University of Oklahoma and an MBA from USC Marshall School of Business.
Laci Costa
Director, Neurovascular Product Marketing